Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here is one cash-producing company that reinvests wisely to drive long-term success and two that may face some trouble.
Two Stocks to Sell:
Doximity (DOCS)
Trailing 12-Month Free Cash Flow Margin: 45.3%
With over 80% of U.S. physicians as members of its digital community, Doximity (NYSE: DOCS) operates a digital platform that enables physicians and other healthcare professionals to collaborate, stay current with medical news, manage their careers, and conduct virtual patient visits.
Why Are We Hesitant About DOCS?
- Products, pricing, or go-to-market strategy may need some adjustments as its 7.9% average billings growth over the last year was weak
- Estimated sales growth of 4.6% for the next 12 months implies demand will slow from its two-year trend
- Costs have risen faster than its revenue over the last year, causing its operating margin to decline by 10.5 percentage points
At $27.71 per share, Doximity trades at 5.8x forward price-to-sales. Dive into our free research report to see why there are better opportunities than DOCS.
Silgan Holdings (SLGN)
Trailing 12-Month Free Cash Flow Margin: 9.5%
Established in 1987, Silgan Holdings (NYSE: SLGN) is a supplier of rigid packaging for consumer goods products, specializing in metal containers, closures, and plastic packaging.
Why Is SLGN Risky?
- Annual revenue growth of 4.7% over the last five years was below our standards for the industrials sector
- High input costs result in an inferior gross margin of 16.8% that must be offset through higher volumes
- Earnings growth underperformed the sector average over the last five years as its EPS grew by just 2.4% annually
Silgan Holdings’s stock price of $41.71 implies a valuation ratio of 10.7x forward P/E. Check out our free in-depth research report to learn more about why SLGN doesn’t pass our bar.
One Stock to Watch:
Dutch Bros (BROS)
Trailing 12-Month Free Cash Flow Margin: 5%
Started in 1992 by two brothers as a single pushcart, Dutch Bros (NYSE: BROS) is a dynamic coffee chain that’s captured the hearts of coffee enthusiasts across the United States.
Why Is BROS on Our Radar?
- Rapid rollout of new restaurants to capitalize on market opportunities makes sense given its strong same-store sales performance
- Same-store sales growth averaged 6% over the past two years, showing it’s bringing new and repeat diners into its restaurants
- Expected revenue growth of 27.7% for the next year suggests its market share will rise
Dutch Bros is trading at $53.11 per share, or 45.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
